Veikirin 10/25/50 10mg/ 25mg/ 50mg Tablet
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression in adults.
Dosage (summary)
Initially 75-150 mg daily; maintenance 50-100 mg daily.
Special Populations
- Elderly
- Severe liver disease
- Cardiac disease
Pregnancy & Breastfeeding
Not established; avoid breastfeeding.
Key Drug Interactions
- MAOIs
- CNS depressants
- Antihypertensives
Contraindications
- Hypersensitivity
- Recent myocardial infarction
- Pregnancy
- Children under 18
Common side effects
- Drowsiness
- Dry mouth
- Constipation
Counselling Points
- Avoid alcohol
- Monitor for sedation
- Do not drive until effects are known
Serious warnings
- Risk of suicidal thoughts
- Cardiac dysrhythmias
- Anticholinergic effects
Important Disclaimer
The Veikirin 10/25/50 10mg/ 25mg/ 50mg Tablet professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
